Resident Memory T Cells as Surrogate Markers of the Efficacy of Cancer Vaccines

Clin Cancer Res. 2016 Feb 1;22(3):530-2. doi: 10.1158/1078-0432.CCR-15-2364. Epub 2015 Nov 5.

Abstract

Cancer vaccine boost via the cervicovaginal rather than the intramuscular route of immunization appears to be crucial to induce genital CD8(+) T cells and tumor regression. This clinical activity is correlated with the ability of the mucosal boost to elicit resident memory T cells in the genital tract.

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Biomarkers
  • CD8-Positive T-Lymphocytes / immunology*
  • Cancer Vaccines*
  • Humans
  • Immunization
  • Immunologic Memory
  • Neoplasms

Substances

  • Biomarkers
  • Cancer Vaccines